BMY
Bristol-Myers Squibb margins
- Stocks
- Healthcare
- NYSE: BMY
- Margins
The Bristol-Myers Squibb shows a gross margin of 70.2%, an operating margin of 24.2%, an EBITDA margin of 30.7%, and a net margin of 18.9%. Operating margin showed the largest year-over-year gain at 10.4 percentage points, whereas gross margin showed the largest decline at 0.1 percentage points.
BMY margin history
Over the last 3 years, Bristol-Myers Squibb's margins averaged 72.66% gross, 7.19% operating, 23.08% EBITDA, and 4.83% net. The current figures show operating, EBITDA, and net margins are above their three-year averages, while gross margin is below its three-year average.
BMY margin expansion
Operating margin expanded by 10.4 percentage points, EBITDA margin by 3.3 percentage points, and net margin by 8.3 percentage points, whereas gross margin contracted by 0.1 percentage points.
BMY Gross margin
In the last 3 years, Bristol-Myers Squibb had an average gross margin of 72.66%. Against its three-year average, Bristol-Myers Squibb's gross margin is currently 70.2%, 2.5 percentage points below its three-year average. Looking back over the last 3 years, Bristol-Myers Squibb's gross margin reached 76.5% at its highest point in Sep 2023 and 69.5% at its lowest in Sep 2025.
BMY Operating margin
Over the last 3 years, Bristol-Myers Squibb had an average operating margin of 7.19%. Against its three-year average, Bristol-Myers Squibb's operating margin is currently 24.2%, 17 percentage points above its three-year average. Looking back over the last 3 years, Bristol-Myers Squibb's operating margin reached 24.2% at its highest point in Jun 2026 and -17.3% at its lowest in Dec 2024.
BMY EBITDA margin
Over the last 3 years, Bristol-Myers Squibb's EBITDA margin averaged 23.08%. The current EBITDA margin of 30.7% is 7.6 percentage points above its three-year average. During this period, EBITDA margin reached a high of 41% in Sep 2023 and a low of 2.5% in Dec 2024.
BMY Net margin
Looking at the last 3 years, Bristol-Myers Squibb had an average net margin of 4.83%. As of the latest period, Bristol-Myers Squibb's current net margin is 18.9%, which is 14.1 percentage points above its three-year average. Looking back over the last 3 years, Bristol-Myers Squibb's net margin reached 18.9% at its highest point in Jun 2026 and -18.5% at its lowest in Dec 2024.
BMY margin group comparison
With a gross margin of 70.2%, BMY stands above the Healthcare sector and the industry average but below its peers average. But in comparison with its Healthcare sector average of 68.5%, Bristol-Myers Squibb's gross margin is only 2.5% higher.
BMY margin peer comparison
Frequently asked questions
What is Bristol-Myers Squibb's gross margin?
For the period ending Jun 30, 2026, BMY recorded a gross margin of 70.2%.
What is Bristol-Myers Squibb's operating margin?
The current operating margin for BMY is 24.2% as of Jun 30, 2026.
What is Bristol-Myers Squibb's EBITDA margin?
For the period ending Jun 30, 2026, BMY recorded an EBITDA margin of 30.7%.
What is Bristol-Myers Squibb's net margin?
As of Jun 30, 2026, BMY has a net margin of 18.9%.
What are the average margins of BMY?
Over the past 3 years, BMY reported average margins of 72.7% gross, 7.2% operating, 23.1% EBITDA, and 4.8% net.
What are the highest historical margins of BMY?
Over the last 5 years, Bristol-Myers Squibb's highest margins were 79.6% gross in Mar 2022, 24.2% operating in Jun 2026, 41.3% EBITDA in Jun 2023, and 18.9% net in Jun 2026.
What are the lowest historical margins of BMY?
Looking back across 5 years, BMY reached its lowest margins at 69.5% gross in Sep 2025, -17.3% operating in Dec 2024, 2.5% EBITDA in Dec 2024, and -18.5% net in Dec 2024.